PMID- 28560422 OWN - NLM STAT- MEDLINE DCOM- 20180326 LR - 20181113 IS - 1791-3004 (Electronic) IS - 1791-2997 (Print) IS - 1791-2997 (Linking) VI - 16 IP - 1 DP - 2017 Jul TI - Effects of maternal acrolein exposure during pregnancy on testicular testosterone production in fetal rats. PG - 491-498 LID - 10.3892/mmr.2017.6624 [doi] AB - Acrolein has been reported to have diverse toxic effects on various organs, including the reproductive system. However, little is known regarding the effects of maternal acrolein exposure on testicular steroidogenesis in male offspring. The present study investigated the effects of acrolein on fetal testosterone production and associated genes. Pregnant Sprague‑Dawley rats were intraperitoneally injected with vehicle (normal saline) or 1, 2 or 5 mg/kg acrolein from gestational day (GD) 14‑20, and fetal testes were examined on GD 21. Fetal body and testicular weights were markedly reduced in pups following exposure to high doses of acrolein (5 mg/kg) in late pregnancy. Notably, in utero exposure of 5 mg/kg acrolein significantly decreased the testicular testosterone level and downregulated the expression levels of steroidogenic acute regulatory protein (StAR) and 3beta‑hydroxysteroid dehydrogenase (3beta‑HSD), whereas the levels of other steroidogenic enzymes, including scavenger receptor class B, cholesterol side‑chain cleavage enzyme and steroid 17 alpha‑hydroxylase/17,20 lyase, were unaffected. Furthermore, the 3beta‑HSD immunoreactive area in the interstitial region of the fetal testes was reduced at a 5 mg/kg dose, whereas the protein expression levels of 4‑hydroxynonenalwere dose‑dependently increased following maternal exposure to acrolein. mRNA expression levels of insulin‑like factor 3, a critical gene involved in testicular descent, were unaltered following maternal acrolein exposure. Taken together, the results of the present study suggested that maternal exposure to high doses of acrolein inhibited fetal testosterone synthesis, and abnormal expression of StAR and 3beta‑HSD may be associated with impairment of the steroidogenic capacity. FAU - Yang, Yuzhuo AU - Yang Y AD - Department of Urology, Peking University Third Hospital, Beijing 100191, P.R. China. FAU - Zhang, Zhe AU - Zhang Z AD - Department of Urology, Peking University Third Hospital, Beijing 100191, P.R. China. FAU - Zhang, Hongliang AU - Zhang H AD - Reproductive Medicine Center, Peking University Third Hospital, Beijing 100191, P.R. China. FAU - Hong, Kai AU - Hong K AD - Department of Urology, Peking University Third Hospital, Beijing 100191, P.R. China. FAU - Tang, Wenhao AU - Tang W AD - Department of Urology, Peking University Third Hospital, Beijing 100191, P.R. China. FAU - Zhao, Lianming AU - Zhao L AD - Department of Urology, Peking University Third Hospital, Beijing 100191, P.R. China. FAU - Lin, Haocheng AU - Lin H AD - Department of Urology, Peking University Third Hospital, Beijing 100191, P.R. China. FAU - Liu, Defeng AU - Liu D AD - Reproductive Medicine Center, Peking University Third Hospital, Beijing 100191, P.R. China. FAU - Mao, Jiaming AU - Mao J AD - Reproductive Medicine Center, Peking University Third Hospital, Beijing 100191, P.R. China. FAU - Wu, Han AU - Wu H AD - Department of Urology, Peking University Third Hospital, Beijing 100191, P.R. China. FAU - Jiang, Hui AU - Jiang H AD - Department of Urology, Peking University Third Hospital, Beijing 100191, P.R. China. LA - eng PT - Journal Article DEP - 20170525 PL - Greece TA - Mol Med Rep JT - Molecular medicine reports JID - 101475259 RN - 0 (Insulin) RN - 0 (Leydig insulin-like protein) RN - 0 (Proteins) RN - 3XMK78S47O (Testosterone) RN - 7864XYD3JJ (Acrolein) SB - IM MH - *Acrolein/adverse effects MH - Animals MH - Female MH - *Fetus MH - Gene Expression Regulation, Developmental/drug effects MH - Insulin/genetics/metabolism MH - Male MH - *Maternal Exposure MH - Pregnancy MH - Proteins/genetics/metabolism MH - Rats MH - Testis/*drug effects/*metabolism MH - Testosterone/*biosynthesis PMC - PMC5482093 EDAT- 2017/06/01 06:00 MHDA- 2018/03/27 06:00 PMCR- 2017/05/25 CRDT- 2017/06/01 06:00 PHST- 2015/11/24 00:00 [received] PHST- 2016/11/29 00:00 [accepted] PHST- 2017/06/01 06:00 [pubmed] PHST- 2018/03/27 06:00 [medline] PHST- 2017/06/01 06:00 [entrez] PHST- 2017/05/25 00:00 [pmc-release] AID - mmr-16-01-0491 [pii] AID - 10.3892/mmr.2017.6624 [doi] PST - ppublish SO - Mol Med Rep. 2017 Jul;16(1):491-498. doi: 10.3892/mmr.2017.6624. Epub 2017 May 25.